Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study

In response to the raging COVID-19 pandemic, Bangladesh started its vaccine administration in early 2021; however, due to the rapid development and launch of the vaccines in the market, many people had concerns regarding the safety of these vaccines. The purpose of this study was to evaluate the sid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahan, Nishat, Rahman, Fahad Imtiaz, Saha, Poushali, Ether, Sadia Afruz, Roknuzzaman, ASM, Sarker, Rapty, Kalam, Khondoker Tashya, Haq, Kashfa, Nyeen, Julkar, Himi, Humayra Zaman, Hossain, Md. Nazmul, Chowdhury, Mahtab Hossain, Uddin, Mostafa Moin, Alam, Nur Haque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544399/
https://www.ncbi.nlm.nih.gov/pubmed/34698203
http://dx.doi.org/10.3390/idr13040080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544399/
https://www.ncbi.nlm.nih.gov/pubmed/34698203
http://dx.doi.org/10.3390/idr13040080

Ejemplares similares